Dossier
esophageal cancer
Coverage of esophageal cancer in the Nexus archive.
- Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer
The article discusses the emergence and ongoing promise of immunotherapy for resectable esophageal cancer, a disease historically associated with poor prognosis. It highlights that immunotherapy has provided hope to patients and clinicians, with recent developments suggesting sustained or improved outcomes.
- New Strategies and Platforms for Gastroesophageal Cancer
Improved understanding of the tumor microenvironment and genomics has led to new therapies for gastroesophageal and esophageal cancer, potentially improving patient outcomes. Some of these therapies have already transitioned from research to application.